Status:
RECRUITING
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
Lead Sponsor:
Ethicon, Inc.
Conditions:
Stress Urinary Incontinence
Eligibility:
FEMALE
21+ years
Brief Summary
The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT ABBREVO® Continence System in women undergoing Mid-urethral sling surgery for Stress Urinar...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subjects who satisfy all of the following criteria will be considered eligible for enrollment in this study:
- Stress urinary incontinence symptoms
- Diagnostic evaluation, a positive cough stress rest, to confirm diagnosis of stress urinary incontinence.
- Female subjects ≥ 21 years of age requiring treatment of SUI
- Desired surgical correction of stress urinary incontinence using synthetic sub-urethral vaginal slings
- Planned surgery for primary stress incontinence without concomitant prolapse surgery
- Patient able and willing to participate in follow-up
- Subject or authorized representative has signed the approved informed consent
- Exclusion Criteria
- Subjects meeting any of the following criteria will be considered not eligible for enrollment in this study:
- Physical or psychological condition which would impair study participation or are unwilling or unable to participate in all required study visits and are unable to complete the questionnaires
- Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of study product
- History of previous synthetic, biologic or fascial sub-urethral sling
- Pregnancy or plans for future pregnancy
- History of bleeding diathesis or current anti-coagulation therapy which cannot be suspended peri-operatively according to site's standard practice.
- Current genitourinary fistula or urethral diverticulum
- Reversible cause of incontinence (i.e. drug effect)
- Contraindication to surgery
Exclusion
Key Trial Info
Start Date :
September 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 27 2037
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT04829357
Start Date
September 9 2021
End Date
February 27 2037
Last Update
December 5 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Female Pelvic Medicine
North Wales, Pennsylvania, United States, 19454
2
Bio-Medical University Rome
Rome, Italy
3
Ospedale San Pietro Fatebenefratelli
Rome, Italy
4
Zelazna Medical Center
Warsaw, Poland